Daiichi Sankyo Articles
UK’s NICE backs GSK’s Hycamtin for cervical cancer and Lilly’s Efient for preventing blood clots
28 October 2009
India’s Ranbaxy and Dr Reddy’s post strong results
27 October 2009
Ranbaxy unit to commercialize Daiichi Sankyo drugs in Mexico
12 October 2009
Japan’s NHI drug pricing system reform makes little progress
8 October 2009
Japan stock market week to June 8, 2009
9 June 2009
Stock Commentary - New York week to June 1, 2009
4 June 2009
JPMA presses for drug price maintenance
2 June 2009
Japan stock market week to May 25, 2009
27 May 2009
Daiichi swings to loss on Ranbaxy buyout
27 May 2009
Daiichi Sakyo presents Evista compliance data
20 May 2009
Further 318 generics added to Japan's NHI list
19 May 2009
Stock Commentary - Europe - week to may 11, 2009
14 May 2009
Japan stock market week to May 11, 2009
12 May 2009
Daiichi Sankyo's Azor improves 24-hour ABP
12 May 2009
ArQule cuts loss on Japanese deals
11 May 2009
Japan stock market week to April 27, 2009
28 April 2009
Oncology market to rise, particularly in Japan
16 April 2009
SCLC drug market wil more than double to $648M in 2017
14 April 2009
Erratum: Daiichi Sankyo US approval for Effient
9 April 2009
Daiichi/Lilly's Efient gets first world launch in UK - first new antiplatelet drug in a decade
9 April 2009
Japan stock market week to April 6, 2009
7 April 2009
Daiichi Sankyo moves Factor Xa drug to Ph III
31 March 2009
Japan stock market week to March 23, 2009
30 March 2009
Gene Bridges' licenses Red/ET to Daiichi Sankyo
30 March 2009
Daiichi will pay off Ranbaxy drop for 20 years
16 March 2009
ArQule expands drug candidate into HCC
16 March 2009
Prasugrel lowers HF risk in high-risk patients
9 March 2009
Japan stock market week to March 2, 2009
9 March 2009
Agility and innovation, at Economist
9 March 2009
US FDA says Ranbaxy falsified data
9 March 2009
Barring prasugrel FDA panelist a "mistake"
2 March 2009
Lilly/Daiichi's Efient cleared in Europe
2 March 2009
Japan stock market week to Feb 9, 2009
16 February 2009
Ranbaxy buy knocks Daiichi into loss
16 February 2009
Japanese stock prices week to Feb 2, 2009
9 February 2009
Daiichi offers to buy further 20% in Zenotech
26 January 2009
Daiichi Sankyo files for approval of silodosin in China
19 January 2009
Japan stock market week to Jan 12, 2009
19 January 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
Japan stock market week to Jan 5, 2009
12 January 2009
FDA 2008 NCE appros exceed expectations
12 January 2009
Daiichi to book a $3.8B loss on Ranbaxy buy
12 January 2009
FDA calls in experts for prasugrel review
12 January 2009
Prasugrel gets nod from CHMP
12 January 2009
Japan stock market week to Dec 15, 2008
22 December 2008
Lilly expects to report loss for full-year 2008 but 2009 guidance unaffected by forex
22 December 2008
Japan stock market week to Dec 8, 2008
15 December 2008
Japan majors hope to bolster lagging shares
15 December 2008
Japan stock market week to Dec 1, 2008
8 December 2008
Japan's doctors want new drugs developed
8 December 2008
S-P claims superior pipeline to competitors; new drugs could make $7B in next 4 years
8 December 2008
Stock Commentary - New York week to Nov 24, 2008
1 December 2008
ArQule bailed out of deeper loss by Daiichi
1 December 2008
Japan stock market week to Nov 24, 2008
1 December 2008
Stock Commentary - New York week to Nov 17, 2008
24 November 2008
Daiichi Sankyo's Sevikar approved in Europe
17 November 2008
Lilly and Daiichi present heart-attack study
17 November 2008
Ranbaxy swings to $81.4M loss in 3rd-qtr
17 November 2008
Japan stock market week to Nov 3, 2008
10 November 2008
Daiichi acquires Merck Serono Turkish staff
10 November 2008
FDA delays NDA reviews despite budget rise
3 November 2008
Japan stock market week to Oct 27, 2008
3 November 2008
Daiichi Sankyo's tender offer for Ranbaxy successful
27 October 2008
Lilly/Daiichi reassure investors on prasugrel
27 October 2008
Japan stock market week to Oct 13, 2008
20 October 2008
Daiichi Sankyo plans to become a leader in antithrombotics with prasugrel and DU-176b
20 October 2008
Japan stock market week to Sept 29, 2008
6 October 2008
Japan stock market week to Sept 22, 2008
29 September 2008
Ranbaxy responds to FDA allegations
29 September 2008
US FTC challenges Fresenius deal
22 September 2008
US FTC challenges Fresenius deal
22 September 2008
Japan stock market week to Sept 8, 2008
15 September 2008
EU Commission clears Daiichi Sankyo's purchase of Ranbaxy
15 September 2008
Japan stock market week to Sept 1, 2008
8 September 2008
Daiichi Sankyo reports on Factor Xa inhibitor
8 September 2008
UPDATE: Prasugrel better than Plavix in preventing ACS in diabetics
8 September 2008
Recurrent events 35% less likely with prasugrel than Plavix
1 September 2008
Biota's novel antiviral "indistinguishable" from oseltamivir
11 August 2008
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
